NEW YORK (GenomeWeb News) – Horizon Discovery today announced a £6.9 million ($10.5 million) final closing to its Series C funding round, bringing the total raised in the round to £18.2 million.

The closing of the round, the Cambridge, UK-based life science research tools firm said, will enable it to transition from a three-year investment phase to an organic growth phase "that it forecasts will deliver sustainable profit" from the second half of this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.